SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
🔥 科研通第二届『
应助活动周
』正在进行中,3月24-30日求助秒级响应🚀,千元现金等你拿。
当前排名🏆
📚 中科院2025期刊分区📊 已更新
飘逸的念烟
Lv1
40 积分
2023-12-31 加入
最近求助
最近应助
互助留言
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
7天前
已完结
Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials
14天前
已完结
R-Cmop and Pola-R-CMP Regimes As First-Line Treatment for Diffuse Large B-Cell Lymphoma with Cardiac Comorbidity
3个月前
已关闭
R-Cmop and Pola-R-CMP Regimes As First-Line Treatment for Diffuse Large B-Cell Lymphoma with Cardiac Comorbidity
3个月前
已关闭
R-Cmop and Pola-R-CMP Regimes As First-Line Treatment for Diffuse Large B-Cell Lymphoma with Cardiac Comorbidity
3个月前
已关闭
Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study
4个月前
已完结
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia
4个月前
已完结
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia
5个月前
已完结
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens
5个月前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
5个月前
已完结
没有进行任何应助
已下载【积分已退回】
3个月前
速度真快,帮大忙了
1年前
速度真快,帮大忙了,感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论